Scarica l'app Stockscreener
146.24
1.30%
-1.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AXSM Giù?
Forum
Previsione
Precedente Chiudi:
$148.17
Aprire:
$148.36
Volume 24 ore:
357.19K
Relative Volume:
0.70
Capitalizzazione di mercato:
$7.37B
Reddito:
$338.46M
Utile/perdita netta:
$-310.96M
Rapporto P/E:
-22.40
EPS:
-6.53
Flusso di cassa netto:
$-132.82M
1 W Prestazione:
-0.89%
1M Prestazione:
+4.69%
6M Prestazione:
+40.48%
1 anno Prestazione:
+62.31%
Intervallo 1D:
$145.10
$149.13
Intervallo di 1 settimana:
$144.00
$150.00
Portata 52W:
$75.56
$152.94
Axsome Therapeutics Inc Stock (AXSM) Company Profile
Nome
Axsome Therapeutics Inc
Settore
Industria
Telefono
(212) 332-3241
Indirizzo
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Confronta AXSM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AXSM
Axsome Therapeutics Inc
|
146.24 | 7.47B | 338.46M | -310.96M | -132.82M | -6.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-01 | Iniziato | B. Riley Securities | Buy |
| 2025-09-03 | Ripresa | Wells Fargo | Overweight |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-03 | Iniziato | Oppenheimer | Outperform |
| 2025-04-07 | Iniziato | Jefferies | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-12-31 | Reiterato | Mizuho | Outperform |
| 2024-09-03 | Iniziato | Wells Fargo | Overweight |
| 2024-08-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-07-22 | Iniziato | Needham | Buy |
| 2024-04-29 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-03-19 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2024-01-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-12-13 | Iniziato | Citigroup | Buy |
| 2023-08-08 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-01-05 | Iniziato | Piper Sandler | Neutral |
| 2022-11-01 | Iniziato | Loop Capital | Buy |
| 2022-09-07 | Ripresa | Mizuho | Buy |
| 2021-08-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-10 | Iniziato | Berenberg | Buy |
| 2021-01-08 | Iniziato | Jefferies | Buy |
| 2020-12-16 | Iniziato | Mizuho | Buy |
| 2020-09-29 | Iniziato | BofA Securities | Underperform |
| 2020-09-10 | Iniziato | Morgan Stanley | Overweight |
| 2020-04-28 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-14 | Iniziato | Cowen | Outperform |
| 2019-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2019-12-17 | Reiterato | H.C. Wainwright | Buy |
| 2019-12-16 | Reiterato | Guggenheim | Buy |
| 2019-10-16 | Iniziato | Guggenheim | Buy |
| 2019-09-18 | Iniziato | William Blair | Outperform |
| 2019-05-28 | Iniziato | SunTrust | Buy |
| 2019-05-23 | Reiterato | H.C. Wainwright | Buy |
| 2019-04-08 | Iniziato | SVB Leerink | Outperform |
| 2019-03-15 | Reiterato | H.C. Wainwright | Buy |
| 2016-10-03 | Ripresa | Brean Capital | Buy |
| 2015-12-15 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-12-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Axsome Therapeutics Inc Borsa (AXSM) Ultime notizie
2 Monster Stocks in the Making - MSN
Castleark Management LLC Buys 19,250 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics (AXSM) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
TFG Asset Management GP Ltd Increases Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
RBC Capital Sticks to Its Buy Rating for Axsome Therapeutics (AXSM) - The Globe and Mail
Axsome Therapeutics, Inc. $AXSM Position Lowered by Eventide Asset Management LLC - MarketBeat
Bellevue Group AG Decreases Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Readies Alzheimer’s Drug Launch With Analyst Backing - Finimize
Axsome Confident On Regulatory, Commercial Outlook for Alzheimer's Agitation Drug Candidate, RBC Says - marketscreener.com
9,555 Shares in Axsome Therapeutics, Inc. $AXSM Purchased by WINTON GROUP Ltd - MarketBeat
How Investors Are Reacting To Axsome Therapeutics (AXSM) Revenue Surge Amid Wider Losses and Strategy Shift - Sahm
Axsome Therapeutics, Inc. $AXSM Shares Sold by HighVista Strategies LLC - MarketBeat
Invesco Ltd. Decreases Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Russell Investments Group Ltd. Boosts Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Stock Slips On Q4 Profit Miss, But Retail Takes It In Stride - MSN
Hood River Capital Management LLC Acquires Shares of 371,104 Axsome Therapeutics, Inc. $AXSM - MarketBeat
Jump Financial LLC Purchases 35,860 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Price-Driven Insight from (AXSM) for Rule-Based Strategy - news.stocktradersdaily.com
Kennedy Capital Management LLC Boosts Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Quantbot Technologies LP Grows Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Norges Bank Acquires New Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Schroder Investment Management Group Has $3.91 Million Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Affinity Asset Advisors LLC Has $5.22 Million Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Insider Selling: Axsome Therapeutics (NASDAQ:AXSM) CEO Sells 10,558 Shares of Stock - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $7,121,346.68 in Stock - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 20,163 Shares - MarketBeat
Can Axsome Therapeutics Inc. (19X) stock sustain breakout momentum2025 Performance Recap & Fast Entry High Yield Tips - Newser
Will Axsome Therapeutics Inc. stock outperform international peersCEO Change & Smart Money Movement Alerts - Newser
Is Axsome Therapeutics Inc. stock recession proof2025 AllTime Highs & Reliable Trade Execution Plans - Newser
Axsome therapeutics CEO Tabuteau sells $11.6 million in shares By Investing.com - Investing.com South Africa
Axsome therapeutics CEO Tabuteau sells $11.6 million in shares - Investing.com
Will Axsome Therapeutics Inc. (19X) stock outperform small cap peersEarnings Recap Summary & Growth Focused Investment Plans - Newser
Will Axsome Therapeutics Inc. stock outperform value stocksBull Run & Risk Controlled Swing Trade Alerts - Newser
Hsbc Holdings PLC Has $10.24 Million Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Is Axsome Therapeutics Inc. (19X) stock trading at attractive multiplesWeekly Trade Report & High Yield Equity Trading Tips - Newser
Rhumbline Advisers Has $6.45 Million Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
What momentum indicators show for Axsome Therapeutics Inc. stockJuly 2025 Action & Risk Managed Trade Strategies - Newser
Is Axsome Therapeutics Inc. (19X) stock included in top ETFsTrade Exit Report & Low Drawdown Trading Strategies - Newser
Axsome (AXSM) Up 5.3% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Granite Investment Partners LLC Has $13.42 Million Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
How Axsome Therapeutics Inc. (19X) stock trades pre earningsJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - Newser
Axsome Therapeutics, Inc. $AXSM Shares Purchased by Swiss National Bank - MarketBeat
2 Under-the-Radar Stocks to Buy Heading Into 2026 - sharewise.com
Axsome Therapeutics (AXSM): Evaluating Valuation Following Recent Share Price Momentum and Pipeline Expansion - Yahoo Finance
2 Under-the-Radar Stocks to Buy Heading Into 2026 - The Motley Fool
Axsome Therapeutics, Inc. $AXSM Shares Sold by Loomis Sayles & Co. L P - MarketBeat
Quadrature Capital Ltd Boosts Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
2,366 Shares in Axsome Therapeutics, Inc. $AXSM Bought by Elevation Point Wealth Partners LLC - MarketBeat
Capital Fund Management S.A. Buys 47,738 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Jefferies Financial Group Inc. Makes New $261,000 Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Inc Azioni (AXSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):